First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
Dieras V, Pop S, Berger F, Dujaric ME, Beuzeboc P, Escalup L, Bidard FC, Cottu PH, LE Tourneau C, Piperno-Neumann S, Laurence V, Robain M, Asselain B, Pierga JY.
Dieras V, et al. Among authors: pierga jy.
Anticancer Res. 2017 Mar;37(3):1403-1407. doi: 10.21873/anticanres.11462.
Anticancer Res. 2017.
PMID: 28314310